Functionally Selective Dopamine D2, D3 Receptor Partial Agonists

Dopamine D2 receptor-promoted activation of Gαo over Gαi may increase synaptic plasticity and thereby might improve negative symptoms of schizophrenia. Heterocyclic dopamine surrogates comprising a pyrazolo[1,5-a]pyridine moiety were synthesized and investigated for their binding properties when low...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 57; no. 11; pp. 4861 - 4875
Main Authors Möller, Dorothee, Kling, Ralf C, Skultety, Marika, Leuner, Kristina, Hübner, Harald, Gmeiner, Peter
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 12.06.2014
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Dopamine D2 receptor-promoted activation of Gαo over Gαi may increase synaptic plasticity and thereby might improve negative symptoms of schizophrenia. Heterocyclic dopamine surrogates comprising a pyrazolo[1,5-a]pyridine moiety were synthesized and investigated for their binding properties when low- to subnanomolar K i values were determined for D2L, D2S, and D3 receptors. Measurement of [35S]GTPγS incorporation at D2S coexpressed with G-protein subunits indicated significant bias for promotion of Gαo1 over Gαi2 coupling for several test compounds. Functionally selective D2S activation was most striking for the carbaldoxime 8b (Gαo1, pEC50 = 8.87, E max = 65%; Gαi2, pEC50 = 6.63, E max = 27%). In contrast, the investigated 1,4-disubstituted aromatic piperazines (1,4-DAPs) behaved as antagonists for β-arrestin-2 recruitment, implying significant ligand bias for G-protein activation over β-arrestin-2 recruitment at D2S receptors. Ligand efficacy and selectivity between D2S and D3 activation were strongly influenced by regiochemistry and the nature of functional groups attached to the pyrazolo[1,5-a]pyridine moiety.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2623
1520-4804
DOI:10.1021/jm5004039